Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 09:36 am Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Avoro Capital Advisors LLC | 3,150,000 6.3% | -85,000 (-2.63%) | View |
| 2023-02-13 10:11 am Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 4,971,660 9.99% | 2,332,885 (+88.41%) | View |
| 2022-11-14 5:11 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Point72 Asset Management L.P. | 3,398,661 7.1% | 3,398,661 (New Position) | View |
| 2022-07-08 4:56 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | BlackRock Inc. BLK | 941,311 2.5% | -2,075,578 (-68.80%) | View |
| 2022-02-14 4:31 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Lion Point Capital LP | 3,629,622 9.87% | -939,312 (-20.56%) | View |
| 2022-02-14 4:28 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Boxer Capital LLC | 0 0% | -4,800,000 (Position Closed) | View |
| 2022-02-14 4:18 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Venrock Healthcare Capital Partners II L.P. | 2,880,096 7.8% | 291,155 (+11.25%) | View |
| 2022-02-11 6:39 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | 683 Capital Management LLC | 1,932,829 5.3% | 111,680 (+6.13%) | View |
| 2022-02-11 5:25 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 2,638,775 7.2% | 586,417 (+28.57%) | View |
| 2022-02-11 10:01 am Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Avoro Capital Advisors LLC | 3,235,000 8.8% | 2,858 (+0.09%) | View |
| 2022-02-02 7:18 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | BlackRock Inc. BLK | 3,016,889 8.2% | 936,798 (+45.04%) | View |
| 2021-08-20 4:36 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 2,052,358 5.6% | 2,052,358 (New Position) | View |
| 2021-02-16 4:09 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Venrock Healthcare Capital Partners II L.P. | 2,588,941 7.3% | -3,913,899 (-60.19%) | View |
| 2021-02-16 3:28 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Bain Capital Life Sciences Fund L.P. | 1,298,178 3.6% | -4,092,744 (-75.92%) | View |
| 2021-02-12 3:55 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Lion Point Capital LP | 4,568,934 12.2% | -1,805,806 (-28.33%) | View |
| 2021-02-12 08:14 am Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Avoro Capital Advisors LLC | 3,232,142 9.09% | 3,232,142 (New Position) | View |
| 2021-02-11 08:16 am Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,462,500 4.11% | 1,462,500 (New Position) | View |
| 2021-02-02 2:56 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | BlackRock Inc. BLK | 2,080,091 5.8% | 2,080,091 (New Position) | View |
| 2021-01-11 5:00 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | 683 Capital Management LLC | 1,821,149 5.1% | 1,821,149 (New Position) | View |
| 2020-09-29 4:49 pm Purchase | 13D | MARINUS PHARMACEUTICALS INC MRNS | Domain Partners VI L.P. | 619,221 2% | 619,221 (New Position) | View |